The surgeon and best-selling author says he will use role to incubate better models of health care.

  • Analysis

CDC's latest Youth Risk Behavior Surveillance survey has mostly good news.

The opioid crisis helped IV Tylenol grow into a $300 million-a-year drug. But pills that costs pennies might work just as well.

People who took multiple prescriptions that carried the side effect were more likely to be depressed.

A new health care legal battle over Obamacare

Dozens of companies increased drug prices in May

Will the public spotlight help bring drug prices down?

Swiss drugmaker says the agreement with Trump lawyer was 'an error'

Former FDA commissioner Mark McClellan leads the Duke University center that was the only institution eligible for the $4.2 million federal grant.

A rarity in pharma: a drug price hike abandoned.

Load More